About the Company
we are a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases, particularly those treated in hospital-based settings. due to drug-resistant and newly-emerging pathogens, infections in the hospital are already the fourth leading cause of death in the united states, following heart disease, cancer and stroke. we address multi-drug resistant infections using our therapeutic products from our lysin and monoclonal antibody platforms to target the conserved regions of either bacteria or viruses. our strategy is to use our first in class therapies to achieve a leadership position in the treatment of life-threatening infectious diseases, including drug-resistant pathogens. we plan to pursue commercialization of therapeutic products through discovery, acquisition and development of protein and antibody products. our novel lysins are enzymes that are produced in the life cycle stage of bacteriophage, a virus that infects and kills ba
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CFRX News
SSG Advises the Chapter 7 Trustee of ContraFect Corporation in Sale of Substantially All Intellectual Property Assets
SSG Capital Advisors served as the investment banker to the Chapter 7 Trustee of ContraFect Corporation, in the sale of substantially all intellectual property assets to Aurobac Therapeutics SAS. The ...
ContraFect Stock (OTC:CFRXQ), Quotes and News Summary
ContraFect Corp is a late clinical-stage biotechnology company focused on the discovery and developm ...
What's Going On With ContraFecta Stock Today
ContraFect Corporation (NASDAQ: CFRX) shares are trading higher Thursday morning.However, there is no specific news to justify the move. Wednesday morning, ContraFect announced the dosing of the ...
FILAMENT HEALTH ANNOUNCES APPOINTMENT OF MICHAEL MESSINGER TO ITS BOARD OF DIRECTORS
Prior to joining Filament's Board, Mr. Messinger held executive and financial reporting roles with publicly traded, Nasdaq-listed companies ContraFect Corporation ("ContraFect") and Lexicon ...
ContraFect Corporation (CFRXQ) Stock Historical Prices & Data - Yahoo Finance
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Duke Energy Corp DUK
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
S-Corp vs LLC: How To Discern What You Need
Although you have several options, many business owners narrow their choice down to an S-corp vs. an LLC. Although S-corps and LLCs share some similar features, both come with their own set of ...
Clover Corp.
Clover Corp. Ltd. is engaged in research and product development of food supplements, pharmaceutical and nutraceuticals. The company focuses on the delivery of bioactive ingredients using ...
Scales Corp.
Scales Corp. Ltd. is a agribusiness group that operates and provides services to New Zealand's primary export sector. It operates though the following segments: food ingredients, horticulture ...
LLC vs. corporation: Differences, pros and cons
The two most common corporation types are C corporations (C corps) and S corporations (S corps). C corps are what we generally think of as traditional corporations, subject to double taxation ...
Chesapeake Energy Corp.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Is Uranium Energy Corp Stock a Buy?
A commodity-focused business like Uranium Energy Corp (NYSEMKT: UEC) can be very volatile. That's not surprising when you consider that the product it sells, uranium, is a bit volatile.
Loading the latest forecasts...